Corporate News 17-Jun-15
Orchid Chemicals & Pharmaceuticals receives approval for ANDA for Gemifloxacin Mesylate Tablets
From USFDA
Orchid Chemicals & Pharmaceuticals announced that the Company has received approval from the US FDA for the Abbreviated New Drug Application (ANDA) for Gemifloxacin Mesylate Tablets (320 mg) with 180 days of generic drug exclusivity.
Previous News
Orchid Pharma hits 52-week high on receiving EMA nod for Exblifep
( Hot Pursuit - 30-Jan-24 12:55 )
Orchid Pharma hits the roof on launching QIP issue
( Hot Pursuit - 23-Jun-23 11:26 )
Broader mkt underperforms; metal stocks lose shine
( Market Commentary - Mid-Session 23-Jun-23 11:35 )
Orchid Pharma reports consolidated net loss of Rs 15.01 crore in the June 2022 quarter
( Results - Announcements 11-Aug-22 08:49 )
Orchid Pharma receives EIR report on closure of PADE inspection
( Corporate News - 08-Jan-18 19:58 )
Orchid Chemicals & Pharmaceuticals net profit declines 66.47% in the March 2012 quarter
( Results - Announcements 15-May-12 10:57 )
Maral Overseas Ltd leads gainers in 'B' group
( Hot Pursuit - 30-Jan-24 12:15 )
Orchid Pharma to conduct board meeting
( Corporate News - 13-Jul-21 09:47 )
Orchid Pharma to hold AGM
( Corporate News - 07-Dec-20 12:03 )
Orchid Pharma to announce Quarterly Result
( Corporate News - 02-Aug-22 11:28 )
Orchid Chemicals & Pharmaceuticals Approval for extension of Financial Year
( Corporate News - 12-Jul-13 11:22 )
Other Stories
Tridhya Tech to convene board meeting
03-Jul-24 20:06
Sonu Infratech schedules EGM
03-Jul-24 19:59
Sakuma Exports to convene AGM
03-Jul-24 19:59
Time Technoplast repays commercial paper
03-Jul-24 18:31
Board of Aditya Vision approves stock split and listing of share on NSE
03-Jul-24 18:24
Pricol director resigns
03-Jul-24 18:21
Board of VMS Industries recommends first interim dividend
03-Jul-24 17:49
Lakshmi Machine Works to declare Quarterly Result
03-Jul-24 17:44
Modison to convene AGM
03-Jul-24 17:43
Sybly Industries to discuss results
03-Jul-24 17:43
Back
Top
